Atlas Trials

Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients

Clinical trial NCT06189170 · COMPLETED

Trial details

NCT number
NCT06189170
Sponsor
Kariya Pharmaceuticals
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Safety IssuesTolerance
Start date
2024-08-01
Primary completion
2026-06-15
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.